I. Singer et S. Nisam, THERE SHOULD NEVER BE ANOTHER ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATOR (AVID) TRIAL, The American journal of cardiology, 80(6), 1997, pp. 766
The Antiarrhythmics Versus Implantable Defibrillator (AVID) trial was
halted recently, following a demonstration of 38% improved survival at
1 year in patients randomized to defibrillators. Although the trial r
eaffirms the superiority of implantable cardiac defibrillators over an
tiarrhythmic drugs for therapy of aborted sudden arrhythmic death, the
authors provide an opinion that the trial was unnecessary and that th
e trial was flawed, raising serious scientific and ethical questions a
bout the trial's conduct.